The BCS, BDDCS, and Regulatory Guidances

被引：68

作者：

Chen, Mei-Ling ^{[1
]}

Amidon, Gordon L. ^{[2
]}

Benet, Leslie Z. ^{[3
]}

Lennernas, Hans ^{[4
]}

Yu, Lawrence X. ^{[5
]}

机构：

[1] US FDA, Off Pharmaceut Sci, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA

[2] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA

[3] Univ Calif San Francisco, Sch Pharm & Med, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA

[4] Uppsala Univ, Dept Pharm, Uppsala, Sweden

[5] US FDA, Ctr Drug Evaluat & Res, Off Gener Drugs, Off Pharmaceut Sci, Rockville, MD 20857 USA

来源：

PHARMACEUTICAL RESEARCH | 2011年 / 28卷 / 07期

关键词：

BCS; BDDCS; biopharmaceutics classification system; biopharmaceutics drug disposition classification system; drug metabolism; drug permeability; BIOPHARMACEUTICS CLASSIFICATION-SYSTEM; DRUG DISPOSITION CLASSIFICATION; PERMEABILITY; ABSORPTION;

D O I：

10.1007/s11095-011-0438-1

中图分类号：

O6 [化学];

学科分类号：

070301 [无机化学];

摘要：

引用

页码：1774 / 1778

页数：5

共 19 条

[1]

Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].

Artursson, P ;

Palm, K ;

Luthman, K .

ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43

[2]

The use of BDDCS in classifying the permeability of marketed drugs [J].

Benet, Leslie Z. ;

Amidon, Gordon L. ;

Barends, Dirk M. ;

Lennernas, Hans ;

Polli, James E. ;

Shah, Vinod P. ;

Stavchansky, Salomon A. ;

Yu, Lawrence X. .

PHARMACEUTICAL RESEARCH, 2008, 25 (03) :483-488

[3]

The biopharmaceutics classification system (BCS): Class III drugs - better candidates for BA/BE waiver? [J].

Blume, HH ;

Schug, BS .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 9 (02) :117-121

[4]

The Use of Drug Metabolism for Prediction of Intestinal Permeability [J].

Chen, Mei-Ling ;

Yu, Lawrence .

MOLECULAR PHARMACEUTICS, 2009, 6 (01) :74-81

[5]

*COMM MED PROD HUM, 2010, GUID INV BIOEQ LENC

[6]

High-Permeability Criterion for BCS Classification: Segmental/pH Dependent Permeability Considerations [J].

Dahan, Arik ;

Miller, Jonathan M. ;

Hilfinger, John M. ;

Yamashita, Shinji ;

Yu, Lawrence X. ;

Lennernas, Hans ;

Amidon, Gordon L. .

MOLECULAR PHARMACEUTICS, 2010, 7 (05) :1827-1834

[7]

GL A, 1995, Pharm Res, V12, P413

[8]

Computational models to assign biopharmaceutics drug disposition classification from molecular structure [J].

Khandelwal, Akash ;

Bahadduri, Praveen M. ;

Chang, Cheng ;

Polli, James E. ;

Swaan, Peter W. ;

Ekins, Sean .

PHARMACEUTICAL RESEARCH, 2007, 24 (12) :2249-2262

[9]

Intestinal permeability and its relevance for absorption and elimination [J].

Lennernas, H. .

XENOBIOTICA, 2007, 37 (10-11) :1015-1051

[10]

The use of biopharmaceutic classification of drugs in drug discovery and development:: current status and future extension [J].

Lennernäs, H ;

Abrahamsson, B .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (03) :273-285

← 1 2 →